LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Home・Aktien・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Geschlossen

BrancheGesundheitswesen

22.58 -3.75

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

22.34

Max

22.67

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.8M -21M
Verkäufe	4.1M 83M
Gewinnspanne	-25.695
Angestellte	756
EBITDA	4.8M -19M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+74.74% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	23. Apr. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-391M 1.5B
Vorheriger Eröffnungskurs	26.33
Vorheriger Schlusskurs	22.58

Nachrichtenstimmung

By Acuity

100%

332 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

52.655 / 56.31 Unterstützung & Widerstand

PROCEPT BioRobotics Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Feb. 2026, 23:53 UTC

Heiße Aktien

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27. Feb. 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28. Feb. 2026, 21:36 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. Feb. 2026, 15:20 UTC

Ergebnisse

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28. Feb. 2026, 14:43 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. Feb. 2026, 14:38 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28. Feb. 2026, 13:47 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. Feb. 2026, 13:44 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28. Feb. 2026, 13:14 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28. Feb. 2026, 02:32 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28. Feb. 2026, 02:00 UTC

Akquisitionen, Fusionen, Übernahmen

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28. Feb. 2026, 02:00 UTC

Akquisitionen, Fusionen, Übernahmen

Six Months, 9 Offers and $81 Billion. How -2-

28. Feb. 2026, 00:01 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27. Feb. 2026, 23:46 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27. Feb. 2026, 23:33 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27. Feb. 2026, 21:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

27. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. Feb. 2026, 21:30 UTC

Ergebnisse

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27. Feb. 2026, 21:30 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27. Feb. 2026, 21:20 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27. Feb. 2026, 21:17 UTC

Ergebnisse

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27. Feb. 2026, 21:10 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27. Feb. 2026, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27. Feb. 2026, 21:00 UTC

Ergebnisse

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27. Feb. 2026, 20:31 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27. Feb. 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27. Feb. 2026, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27. Feb. 2026, 20:12 UTC

Market Talk

Nike Seen With Further Challenges in China -- Market Talk

27. Feb. 2026, 19:44 UTC

Market Talk

Gold Caps Historic Month -- Market Talk

27. Feb. 2026, 19:39 UTC

Ergebnisse

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

Peer-Vergleich

Kursveränderung

PROCEPT BioRobotics Corp Prognose

Kursziel

By TipRanks

74.74% Vorteil

12-Monats-Prognose

Durchschnitt 41.29 USD 74.74%

Hoch 62 USD

Tief 20 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für PROCEPT BioRobotics Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für PROCEPT BioRobotics Corp – Dist abgegeben haben.

Technischer Score

By Trading Central

52.655 / 56.31Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.